DENVER, CO, April 16 /CNW Telbec/ - Medical International Technology Inc.
(MDLH. PK) (http://www.mitcanada.ca http://www.mitinvest.ca), is pleased to
announce that its subsidiary Medical International Technologies (MIT Canada)
Inc. has signed a minimum of six (6) million dollars exclusive "OEM" (Original
Equipment Manufacturer) agreement for a period of 5 years with a Malaysian
distributor for its Needle-Free Jet-Injector, models Med-Jet(R) MBX and
Med-Jet(R)-H-III to be used in cosmetics, plastic surgeries, and medical
applications, in many countries around the world. MIT is also in discussion
with the same distributor for a new product that "MIT" will introduce within
the next six months for the same niche market.
This "OEM" agreement will not prevent "MIT" from selling its own brand in
the same market around the world; rather, it will help introduce "MIT's"
unique technology to doctors worldwide.
"MIT" has already supplied the Malaysian distributor with over 80 units
to cover his initial clients' demands in Malaysia, Philippines, and Vietnam.
Moreover, they have participated in two of the largest exhibition for
cosmetics and plastic surgeries in Asia, Hong Kong, and Shenzhen, China. The
results were overwhelming and more orders were placed with an even larger
order of one hundred units expected before the end of May 2009. "MIT's"
Malaysian distributor is marketing the Med-Jet(R) all over Asia. His later
focus will be placed on the European market.
"MIT's" technology is the outcome of more than twenty-eight years of
research and development and the driving force behind the Med-Jet(R) product
line for humans and the Agro-Jet(R) product line for animals.
"MIT" is consolidating its efforts, strengthening its team, reorganizing
its marketing / sales departments and financial bases in anticipation of its
Medical International Technology Inc. is pleased to continue providing a
safe and effective means to help prevent the spread of deadly diseases to both
humans and animals through the use of the Med-Jet(R) and Agro-Jet(R)
needle-free injection system.
Karim Menassa, President
On Behalf of the Board of Directors
About Medical International Technology, Inc. MIT CANADA, with offices in
Montreal, is a subsidiary of Denver, Colorado-based Medical International
Technology, Inc. (MIT USA), which specializes in the development, production,
marketing and sale of needle-free injectors both for humans and animals, for
individual and mass vaccinations.
The statements which are not historical facts contained in this press
release are forward-looking statements that involve certain risks and
uncertainties, including but not limited to risks associated with the
uncertainty of future financial results, additional financing requirements,
development and acquisition of new product lines and services, government
approval processes, the impact of competitive products or pricing a
technological changes, the effect of economic conditions and other
uncertainties, and the risk factors set forth from time to time in the
Company's SEC reports, including but not limited to its annual report on Form
10-KSB; its quarterly reports on Forms 10-QSB; and any reports on Form 8-K.
Medical International Technology Inc. takes no obligation to update or correct
For further information:
For further information: Karim Menassa, President, (514) 339-9355;